Stereotaxis (STXS) Cash from Financing Activities (2010 - 2026)

Stereotaxis' (STXS) quarterly Cash from Financing Activities came in at $4.7 million in Q1 2026, up 14637.5% year-on-year from N/an in Q1 2025, and down 32.18% on a QoQ basis from $7.0 million in Q4 2025.

Stereotaxis (STXS) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Cash from Financing Activities data on file, last reported at $4.7 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 14637.5% year-over-year to $4.7 million in Q1 2026; TTM through Mar 2026 was $19.4 million, a 6404.01% increase from a year earlier, with the FY2025 full-year figure at $14.8 million, up 4870.71% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $4.7 million, down from $7.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for STXS reached as high as $7.7 million in Q3 2025 and fell as low as -$26000.0 in Q2 2023.
  • Historically, Cash from Financing Activities has averaged $1.2 million across 5 years, with a median of $54000.0 in 2022.
  • Across the five-year window, Cash from Financing Activities plunged 145.61% in 2023 and soared 14637.5% in 2026, its largest moves.
  • Year by year, Cash from Financing Activities stood at $61000.0 in 2022, then plunged by 57.38% to $26000.0 in 2023, then soared by 511.54% to $159000.0 in 2024, then jumped by 4273.58% to $7.0 million in 2025, then plunged by 32.18% to $4.7 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $4.7 million in Q1 2026, $7.0 million in Q4 2025, and $7.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -133.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -287.90 Mn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -414.00 Mn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -13.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -255.24 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -164.80 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -75.80 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -50.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -48.13 Mn
10 Stereotaxis 136.49 Mn 121.87 Mn 3.79 Mn 4.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.72 Mn
Mar 31, 2026 4.72 Mn
Dec 31, 2025 6.95 Mn
Dec 31, 2025 6.95 Mn
Sep 30, 2025 7.74 Mn
Sep 30, 2025 7.74 Mn
Jun 30, 2025 34,000.00
Jun 30, 2025 34,000.00
Mar 31, 2025 32,000.00
Mar 31, 2025 32,000.00
Dec 31, 2024 159,000.00
Dec 31, 2024 159,000.00
Sep 30, 2024 80,000.00
Sep 30, 2024 80,000.00
Jun 30, 2024 28,000.00
Jun 30, 2024 28,000.00
Mar 31, 2024 30,000.00
Mar 31, 2024 30,000.00
Dec 31, 2023 26,000.00
Dec 31, 2023 26,000.00